Canopy Growth Corp

CGC ·Healthcare, Drug Manufacturers - General, Ontario, Canada
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $284.6M $269.0M $297.1M $333.3M $475.7M $546.6M $398.8M $12.8M
Cost of Revenue $214.9M $189.5M $216.3M $396.8M $663.1M $479.7M $430.5M $198.1M
Gross Profit $69.7M $79.5M $80.9M $-63.5M $-187.4M $67.0M $-31.7M $28.2M
Gross Margin 24.5% 29.6% 27.2% -19.1% -39.4% 12.2% -7.9% 221.4%
Operating Expenses
Research & Development $2.6M $2.7M $4.6M $21.7M $32.3M $57.6M $61.8M $15.2M
SG&A Expense $160.0M $169.6M $229.4M $342.5M $415.4M $575.4M $693.7M $392.3M
Operating Income $-161.7M $-117.1M $-228.7M $-2.63B $-1.02B $-1.24B $-1.67B $-637.5M
Operating Margin -56.8% -43.5% -77.0% -789.3% -214.2% -227.5% -418.5% -4,996.1%
Interest Expense $38.2M $74.6M $105.4M $126.2M $103.9M $8.5M $6.7M $2.0M
Pretax Income $-262.9M $-507.8M $-507.8M $-3.09B $-267.9M $-1.68B $-1.51B $-707.9M
Income Tax Expense $23.0K $7.1M $12.3M $-5.7M $-8.9M $-13.1M $-121.6M $4.1M
Net Income $-262.9M $-508.9M $-712.2M $-3.31B $-330.6M $-1.67B $-1.39B $-26.3M
Net Margin -92.4% -189.2% -239.7% -993.1% -69.5% -305.6% -347.9% -206.0%
EPS (Basic) $-0.88 $-1.58 $-3.09 $-23.56 $-2.64 $-1.56 $-1.27 $-0.92
EPS (Diluted) $-0.88 $-1.58 $-3.09 $-23.56 $-2.64 $-1.56 $-1.27 $-0.92
Shares Outstanding (Basic) 298.0M 322.7M 224.4M 139.1M 117.4M 1.11B 1.11B
Shares Outstanding (Diluted) 298.0M 322.7M 224.4M 139.1M 117.4M 1.11B 1.11B
Dividends Per Share
← Newer Page 1 of 2 Older →